It is not always easy to detect malignant tumor tissue in the digestive organs. " For example, it is often necessary to take several biopsies in the bile duct before diagnostic clarity is achieved " says Prof. Schirra, Senior Physician at the Medical Clinic II at Ludwig-Maximilians-University (LMU) Munich. It is not possible with currently available diagnostic methods to visually assess whether the site harboring the malignant transformation has been " caught " in the biopsy process. However, the introduction of new methods might improve the success rate considerably in the not too distant future. Using probe-based confocal laser endomicroscopy (pCLE), it is possible, during the endoscopic examination of the bile duct, to identify the pattern of a suspicious area (Figure 1 ). According to a preliminary study by Meining et al. [1] , "the biopsy success rate increased from 75 % to 90 % when pCLE was applied " explained Prof. Schirra. For gastroenterologists, this is a " considerable step forward " .
The new device (Cellvizio ® ; Mauna Kea Technologies, Paris, France) was bought with fi nancial support from the German Research Foundation (DFG), by T.E.A.M., a network of twelve clinics and institutes, most of them being associated with the University Hospital of Munich. T.E.A.M. stands for " Transluminale und Endoskopische Arbeitsgemeinschaft M ü nchen " and according to their spokesperson, Physicist Dr. Herbert Stepp, " its aim is to conduct pioneering scientifi c research in intraoperative diagnostics " .
The development of the intraoperative diagnostics has a tradition at the University Hospital of Munich. In the early 1990s, the laser research laboratory, at that time a part of the urological clinic, developed a fl uorescence method that depicted cancer tissue as a brilliant red color ( Figure 2 ). This has been used routinely since 2005, providing a reliable method for the diagnosis of bladder cancer and brain tumors. It visualizes cancer cells within the bladder epithelium that previously could not been seen or detected with other devices. Using image-processing technology the T.E.A.M. group hopes to further improve this method to enable the mapping of the entire bladder wall in a single high-resolution image.
Prospects of the combined techniques
However, the fl uorescence method does not yield information about the exact type of tissue alteration -a red fl uorescent area can also be a benign infl ammation. " To clarify, this requires the level of microscopic resolution that is now possible with the pCLE " , says Dr. Stepp. Here, the physician pushes a very thin probe into the working channel of an endoscope until it reaches the tissue in order to position the probe onto the area of interest. It is then possible to depict cells that are approximately up to 150 μ m under the tissue surface. The device can be used in organs with a cavity, such as the bladder, the throat or the digestive tract.
However, the pCLE cannot determine the invasion of a tumor into the underlying connective tissue. This can be determined with an ultrasonic probe or -with even better resolution -by using another new method, the optical coherence tomography (OCT). This method is currently being tested at the University Hospital of Munich using two loaned devices (Figure 3 fl at lesions in the oral cavity and taking the tissue sample from these " hot spots " . The same is true for the diagnosis of neoplasia on the cervix, where OCT proved to be a useful adjunct to normal colposcopy in research carried out by Dr. med. J. Gallwas and PD Dr. med. Ch. Dannecker of the Department of Gynecology.
" Just how OCT and pCLE will make progress in the future it is not clear " , commented Dr. Stepp. Several clinical studies have been carried out at the University Clinic of Mainz with the aim of diagnosing intraepithelial neoplasia and colorectal cancer in vivo , and at the same time examining the potential of pCLE in the colon. After about 10 years, patients with chronic infl ammatory colonic disease have a high cancer risk. The fi rst results using pCLE for detection of early neoplasia in these patients are encouraging. The pCLE is so new that the clinical importance has to be investigated in further prospective studies especially in diseases with a high risk of cancer or in small organs which are not easy accessible to forceps biopsies, something that has encouraged Prof. Schirra ' s team to prepare a study using the pCLE in the bile duct. In the esophagus, studies are concerned with the detection of precancerous lesions in patients with " Barrett's syndrome " , a chronic infl ammatory disease. A fi rst clinical study by Sharma et al. [2] showed that additional use of pCLE signifi cantly improved the ability to detect neoplasia in Barrett's esophagus patients compared with high defi nition endoscopy alone.
Outlook
It is possible that intraoperative diagnosis will in the future proceed as follows: fl uorescence diagnostics will be used to localize suspicious tissue areas, followed by microscopic differentiation of the suspicious cells using pCLE in situ , and fi nally detection of the microinvasion of tumor cells into the connective tissue using OCT. However, until this procedure becomes reality, it will have to remain a vision. " Until we decide further " , says Prof. Schirra, " we will continue to take tissue samples and the fi nal decision, as always, will be taken by the pathologist. " Thanks to pCLE, the samples that the pathologist receives are already often better than they were before. Moreover, quite " incidentally " , the value of all new optical methods will be tested for their scientifi c value (Adapted from: " Laserendomikroskopie f ü r die intraoperative Diagnostik " , www.medizin-edv.de).
